<?xml version="1.0" encoding="UTF-8"?>
<p>In defiance of the great efforts recorded, no drug was approved as a specific anti-SARS-CoV-2 treatment up to present. The considerable number of ongoing clinical trials (over 1300) that evaluate multiple potential antivirals represent the future perspectives concerning the elucidation of COVID-19 pathology and finding an appropriate treatment. The information regarding the progress recorded in the field of vaccine development is also optimistic and represents an option of selective and potent intervention.</p>
